Connor Clark & Lunn Investment Management Ltd. grew its position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Free Report) by 86.6% in the 3rd quarter, HoldingsChannel.com reports. The institutional ...

PUREPWR Nutrition announces the launch of HexaBlend Creatine Gummies, a breakthrough in sports supplementation, combining six ...

Summary The Chart of the Day belongs to the pharmaceutical company Eton Pharmaceuticals (ETON) . I found the stock by using ...

Equities research analysts at HC Wainwright dropped their FY2024 earnings per share estimates for shares of Eton ...

Amglidia® has been approved by the European Medicines Agency (EMA) and is commercially available in EuropeStrong strategic fit with Eton’s ...

Reported total revenue of $10.3 million and GAAP Net Income of $0.6 million, or $0.02 per diluted shareEntered into an asset purchase agreement to acquire Increlex® (mecasermin injection)Q3 2024 produ ...

Some of the ingredients include Cluster dextrin, L-Glutamine, Creatine Monohydrate, and Betaine Anhydrous. The carb-based formula is designed to replenish your body's glycogen stores — and it ...

The commercial availability of Betaine Anhydrous, Nitisinone, and PKU GOLIKE® has helped increase the frequency of the Company’s interactions with potential Carglumic Acid prescribers.

It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the ...